166,000 Australians face 2.5-year epilepsy clinic waits
A Senate inquiry into Australia's epilepsy care is set to report on 17 September 2026, with new data showing South Australian adults wait an average 2.5 years for a specialist clinic appointment. The condition affects 166,000 Australians yet trails migraine, stroke and dementia in funding and awareness, contributing to 322 deaths in 2023. Health system leaders will watch whether the findings translate into faster diagnosis pathways, specialist workforce expansion and research funding.
Beat this week
Last 7 days · Health Policy
Impact 5.5/10 (-0.2 vs prior). Counts are stories in our record, not a market forecast.
Open the change reportCoverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 14 percentage points.
This story sits in Health Policy — the counts compare this beat's last 7 days with the previous 7 in our verified record, not a market forecast.
Figures are computed live from our source-verified story record (as of ) The volume change compares this window with the prior 7 days in the same record. — see our methodology for how impact and sentiment are derived.
Healthcare briefing
Key takeaways
- A Senate inquiry into Australia's epilepsy care is set to report on 17 September 2026, with new data showing South Australian adults wait an average 2.5 years for a specialist clinic appointment.
- The condition affects 166,000 Australians yet trails migraine, stroke and dementia in funding and awareness, contributing to 322 deaths in 2023.
- Health system leaders will watch whether the findings translate into faster diagnosis pathways, specialist workforce expansion and research funding.
- illawarramercury.com.au
- irrigator.com.au
In this briefing
Mentioned
Key Intelligence
Key Facts
- 1The average wait for an adult epilepsy clinic appointment in South Australia is 2.5 years, per research by the Australian and New Zealand Association of Neurologists and the Epilepsy Society of Australia.
- 2Epilepsy affects 166,000 Australians, making it the fourth most common neurological disorder after migraines, strokes and dementia.
- 3Epilepsy was linked to 322 deaths in Australia in 2023, according to the Australian Institute of Health and Welfare.
- 4Adelaide patient Dawn Kenny waited more than five years for an epilepsy diagnosis and 40 years to learn the cause of her seizures, at times enduring up to 20 seizures a day.
- 5A Senate inquiry into epilepsy diagnosis, stigma and funding is due to hand down its findings on 17 September 2026.
- 6Advocates argue savings from avoided hospital admissions will 'generate massive returns' on public investment in epilepsy infrastructure, research and treatment.
There are brilliant doctors here, but the funding just isn't there.
Speaking to AAP about her 40-year diagnostic journey
Advocates warn long waits raise premature death risk and avoidable hospital admissions
Analysis
For healthcare leaders, a 2.5-year average wait for an adult epilepsy clinic appointment is not just a patient-experience statistic, it is a measurable failure of access, triage and specialist workforce capacity. Epilepsy affects 166,000 Australians and was linked to 322 deaths in 2023, yet it consistently loses out on funding and attention to higher-profile neurological conditions. With a Senate inquiry due to report on 17 September 2026, health systems face pressure to redesign referral pathways, expand telehealth and justify the case that earlier intervention cuts avoidable hospital admissions.
A Senate inquiry into Australia's epilepsy care system is set to hand down its findings on 17 September 2026, and the testimony and data released ahead of that deadline reveal a neurological condition that affects 166,000 Australians yet remains chronically underfunded, stigmatised and, in the words of one patient, 'pushed under the counter.' The catalyst for renewed scrutiny is a profile of Dawn Kenny, a 72-year-old Adelaide resident, whose 40-year search for the cause of her seizures has become a case study in the human cost of delayed and fragmented neurological care.
Research by the Australian and New Zealand Association of Neurologists and the Epilepsy Society of Australia puts the average wait for an adult epilepsy clinic appointment in South Australia at two-and-a-half years.
Kenny's story is a catalogue of system failures. She took cocktails of medications and endured what she describes as horrific side effects, at times suffering as many as 20 seizures a day. More than five years passed before she was formally diagnosed with epilepsy, and the underlying cause of her disease remained a mystery for decades, complicating treatment. Despite living in a capital city, she waited months between appointments and travelled hundreds of kilometres between doctors, neurologists and hospital stays, ultimately flying to Melbourne for a rare surgery because the help was not available in Adelaide. 'There are brilliant doctors here, but the funding just isn't there,' she told AAP.
The scale of the problem extends far beyond a single patient. Research by the Australian and New Zealand Association of Neurologists and the Epilepsy Society of Australia puts the average wait for an adult epilepsy clinic appointment in South Australia at two-and-a-half years. Epilepsy is the fourth most common neurological condition in the country, behind only migraines, strokes and dementia, yet it receives a fraction of the public attention and resourcing those conditions command. The Australian Institute of Health and Welfare's most recent tally attributes 322 deaths to epilepsy in 2023. Although the condition is not usually fatal, advocacy groups argue that long diagnostic waits directly increase the risk of premature death and drive up avoidable hospital admissions.
The economic argument is central to the campaign for change. Advocates contend that the savings generated by preventing avoidable hospital admissions will 'generate massive returns' on any public money the government invests in epilepsy infrastructure, research and treatment. That return-on-investment framing is deliberately tailored to a fiscal environment in which new health spending must be justified against measurable downstream savings. If the Senate inquiry endorses that logic, it could unlock funding for specialist clinics, faster diagnostic pathways, expanded neurology and epileptology workforces, and greater research investment, all of which would directly address the wait-time bottleneck Kenny experienced.
What to Watch
Stigma and misconception are equally powerful barriers. Kenny described friends shying away because they assumed her epilepsy meant she would be 'lying on the ground jerking,' when in fact her seizures present differently. That public ignorance, the inquiry is told, slows diagnosis, discourages people from seeking care and compounds the social isolation of patients. It also helps explain why a condition affecting 166,000 people can remain low on the policy agenda despite a measurable mortality toll and decades-long diagnostic odysseys.
For health system leaders, the story carries specific operational implications. A 2.5-year average wait for a specialist clinic signals a workforce and referral-pathway problem that cannot be solved by funding alone; it requires redesign of triage, expanded use of telehealth for regional and even metropolitan patients, and better integration between primary care and specialist neurology. The fact that Kenny, living in a capital city, still had to travel interstate for surgery underscores that access inequity is not purely a rural problem. As the 17 September findings approach, providers, payers and policymakers will be watching whether the inquiry translates lived experience and clinical data into concrete recommendations on diagnosis speed, specialist capacity and stigma reduction, and whether those recommendations are backed by budget commitments.
Source cluster
Primary reporting
- illawarramercury.com.auEpilepsy pushed under with years - long treatment wait
- irrigator.com.auEpilepsy pushed under with years - long treatment wait
Cite This Page
"166,000 Australians face 2.5-year epilepsy clinic waits." Healthcare Intelligence Brief, September 12, 2026. https://gethealthbrief.com/story/epilepsy-clinic-wait-times-senate-inquiry-australia
How we covered this story
Every story in our healthcare coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.
Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the healthcare space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.
Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.
| Signal on this page | What it tells you |
|---|---|
| Verified by N sources | Independent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly. |
| Impact score (1-10) | Regulatory + financial + operational weight. 8+ signals an experienced-operator action item. |
| Sentiment | Five-tier classification trained on labeled healthcare-specific corpora. |
| Timeline | Where applicable, the related-events sequence that contextualizes today's development. |